Tags: pfizer diabetes drug | novo | ozempic

Pfizer Diabetes Drug Scores Weight Loss Like Ozempic

Pfizer Diabetes Drug Scores Weight Loss Like Ozempic
(AP)

Monday, 22 May 2023 02:47 PM EDT

Pfizer Inc.'s diabetes drug resulted in weight loss similar to that of Novo Nordisk's Ozempic in a mid-stage study testing it in patients with type 2 diabetes, according to a study published in JAMA Network.

Shares of Pfizer rose about 4.5% following the news.

Data confirms results that were published last year by Pfizer.

The U.S. drugmaker's danuglipron belongs to a class of drugs which mimic the gut hormone glucagon-like peptide-1 (GLP-1) that work by suppressing appetite.

Danuglipron could help Pfizer enter a potential $100 billion weight-loss drug market.

© 2024 Thomson/Reuters. All rights reserved.


StreetTalk
Pfizer Inc.'s diabetes drug resulted in weight loss similar to that of Novo Nordisk's Ozempic in a mid-stage study testing it in patients with type 2 diabetes, according to a study published in JAMA Network.
pfizer diabetes drug, novo, ozempic
89
2023-47-22
Monday, 22 May 2023 02:47 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Get Newsmax Text Alerts
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved